Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Nutriventia's Prolanza Receives Health Canada Approval - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Nutriventia’s Prolanza Receives Health Canada Approval

The sustained-release ashwagandha ingredient is efficacious at doses of 300 mg, and suitable for a variety of delivery formats.

Author Image

By: Mike Montemarano

Associate Editor, Nutraceuticals World

Photo: Eskymaks | Adobe Stock

Nutriventia Ltd. has received approval from Health Canada for Prolanza, a clinically-studied sustained-release ashwagandha ingredient. The ingredient has received a natural product number, authorizing its sale as a licensed natural health product.

Health Canada’s approval recognizes the safety, quality, and efficacy of the ingredient, allowing it to be marketed to Canadian consumers. In 300 mg capsules, the ingredient has been shown to help manage measures of sleep, stress, and visual memory.

“This approval marks a significant milestone in Nutriventia’s global mission to deliver scientifically validated, consumer-centric natural ingredients,” said Vishal Shah, co-founder of Nutriventia. “With Prolanza, we bring the next generation of ashwagandha to Canada, combining traditional wisdom with modern delivery technology. As more people are expected to add ashwagandha to their daily self-care routines, we are excited that Canadian consumers may now enjoy the benefits of Prolanza in an easy-to-consume low dose. They can also be assured of its efficacy as demonstrated by our clinical trials.”

Prolanza was made using the company’s E.D.G.E. platform to offer sustained-release benefits. It will be available to formulation partners in Canada across capsules, tablets, gummies, and other modern delivery formats.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics